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Abstract Phosphoethanolamine derivatives of the bacte-
rial saccharide L-glycero-D-manno-heptose have been
prepared using a phosphoramidite-based coupling reaction
at position 4 of a side-chain-protected 2,3-O-orthoester
methyl heptoside and at position 3 of a 3,4-diol heptoside,
respectively. Global deprotection afforded the corre-
sponding 2-aminoethylphosphodiester derivatives as
substrates for crystallographic and binding studies with
lectins and antibodies targeting the inner core structure of
bacterial lipopolysaccharides.
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Introduction
The outer membrane of the cell wall of Gram-negative
bacteria harbors higher carbon sugars as characteristic
components, which occur in the inner core region of bac-
terial lipopolysaccharides (LPS), but have also been
detected in capsular polysaccharides (CPS) [1]. Heptoses
of the L-glycero-D-manno configuration (L,D-Hep), in
particular, constitute a structurally conserved domain in
Enterobacteriaceae, such as in Escherichia coli, Salmonella
or Yersinia, and are common LPS core determinants in the
genera Haemophilus, Pseudomonas, Helicobacter, or
Neisseria [2, 3]. Heptoses contribute toward many
biomedically important interactions with the complement
system, antibodies and lectins, and these features have been
substantiated by recent data from crystallographic and
glycan array studies [4–9]. These binding interactions and
specificities are further modulated by additional phosphate
substituents in the pyranose ring as well as at the exocyclic
side chain.
Among the phosphate containing appendices, 2-ami-
noethyl phosphodiester (PEtn) groups have been found at
positions 3, 4, 6, and 7 of L,D-Hep, and the group of
Oscarson has successfully prepared 4-O- , 6-O- , and 7-O-
substituted (2-aminoethyl)phosphate monoheptosides as
well as various 3-O- and 6-O-PEtn substituted LPS
oligosaccharides to unravel the structural basis for cross-
reactive antibodies against Neisseria meningitidis and
Haemophilus influenzae, respectively [10–13]. Recently,
the structure of an antigen-binding fragment (Fab) from the
bactericidal monoclonal antibody LPT3-1 complexed to an
inner core octasaccharide fragment of N. meningitidis has
been solved, which had been isolated via KOH treatment
from the bacterial lipooligosaccharide [14]. The isolation
protocol, however, leads to hydrolysis of the
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phosphoethanolamine units. As the 3-O-PEtn substituent is
present in*70% of N. meningitidis strains and constitutes
a relevant epitope for the neutralizing antibodies, chemical
synthesis is needed to provide material for binding and
crystallographic studies [15]. For this purpose, we have set
out to access both 3-O- and 4-O-substituted heptosides
starting from a common intermediate with a minimum
number of protecting group manipulations.
Results and discussion
The previously reported 6,7-O-TBDPS protected heptoside
1 served as a versatile precursor for the introduction of the
PEtn moiety via intermediate 2,3-orthoester formation as
shown for the synthesis of 4-O-monophosphate derivatives
[16]. In our hands, a three step sequence performed in a
one-pot reaction could be elaborated to give a fair yield of
the phosphotriester derivative 5 (Scheme 1). First, the
reaction of 1 with a,a,a-triethoxytoluene (2) in the presence
of camphorsulfonic acid (CSA) led to the intermediate
orthoester 3, which was followed by the application of the
phosphoramidite procedure with [2-(benzyloxy-diiso-
propylamino-phosphanyloxy)ethyl]-carbamic acid benzyl
ester (4) promoted by 1H-tetrazole, and the ensuing oxi-
dation of the resulting phosphite with meta-
chloroperbenzoic acid (mCPBA) [17–19]. Since the phos-
phorylated orthoester 5 was present as a mixture of four
diastereoisomers, the product mixture was then separated
into individual components to exclude the presence of
potential impurities in the subsequent deprotection steps.
MPLC separation allowed the isolation of a 1:3 mixture of
the phosphorylated endo orthobenzoates 5a, 5b and exo-
isomers 6a, 6b in 56% overall yield for three steps, fol-
lowed by further HPLC separation of the phosphate
diastereomers; no attempts, however, for assignment of the
stereogenic center at phosphorus were undertaken.
Assignment of the exo/endo configuration was based on the
high-field shift of the exo-oriented OCH2 group at
3.30 ppm compared to the corresponding low-field shifted
signal of the endo-isomer at 3.80 ppm [20].
Next, the endo/exo-orthoester derivatives 5a and 6a
(representing one of the diastereomeric forms on phos-
phorus) were subjected to acid-promoted orthoester
opening, which produced the homogeneous 2-O-benzoyl
derivative 7 in 91% yield. Compound 7 is equipped with an
orthogonal protecting group pattern which allows access to
chain elongation at position 3, as well as at the exocyclic
side-chain positions. Removal of the 1,1,3,3-tetraisopropyl-
1,3-disiloxane-1,3-diyl group was achieved by treatment of
7 with triethylamine trifluoride (TREAT). The reaction had
to be monitored until full removal of the monofluorinated
silyl intermediate (Ref. [16]) by TLC, to afford triol 8 in
83% yield. Hydrogenation of 8 was uneventful and gave
the phosphodiester 9 in 93% yield. Cleavage of the benzoyl
ester under Zemple´n transesterification conditions was
sluggish but eventually provided the 4-O-PEtn derivative
10 in good yield. Optical rotation values and 13C NMR data
matched the previously reported data of 10, which, how-
ever, had been synthesized via a different route based on
H-phosphonate coupling chemistry [10].
The orthoester approach was then applied for the syn-
thesis of the 3-O-substituted derivative 16 (Scheme 2). 1
was subjected to CSA-promoted orthoester formation with
1,1,1-trimethoxyethane to give 2,3-O-orthoacetate 11,
which was not isolated but directly converted into the 2-O-
acetate 12 in 71% yield. The structure of ester 12 was
readily assigned on the basis of the low-field shifted H-2
signal at 5.02 ppm. Based on previous evidence that a
Scheme 1
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hydroxyl group adjacent to an axial one in a cis-vicinal diol
is more reactive, and that the 4-OH group in a manno-
pyranoside is much less reactive, a direct regioselective
phosphorylation was expected to directly lead to the 3-O-
substituted phosphoester, thereby avoiding additional pro-
tecting group manipulations [21, 22]. Thus,
phosphorylation of diol 12 using 4 and 1H-tetrazole was
followed by oxidation with mCPBA. The 3-O-substituted
derivative 13 could then be separated from additional
phosphorylated species by chromatography, and was iso-
lated as a diastereomeric mixture in 32% yield.
The structural assignment of 13 was based on the 1H-31P
correlated HMBC spectrum, which showed the connectiv-
ity of H-3 to the phosphate unit, as well as on the low-field
shifted H-3 signal at 4.21 ppm.
Similar to 6, phosphotriester 13 was then treated with
TREAT to give triol 14 in 70% yield, which was hydro-
genated in the presence of 10% Pd–C in MeOH containing
1% acetic acid. The addition of the acid was needed to
prevent formation of N-methylated products [23]. Removal
of the 2-O-acetyl group was carried out by reaction of 15
with triethylamine in aqueous MeOH and furnished the
deprotected zwitterionic glycoside 16 in 63% yield [24].
The structures of 10 and 16 were fully confirmed by their
13C NMR data, which showed a characteristic downfield
shift of the respective carbons C-4 and C-3, respectively,
involved in the phosphodiester linkage as well as
heteronuclear JC,P coupling interactions of C-4 and C-5 for
9 and C-3 and C-4 for 16 (Table 1). Similar JC,P coupling
interactions were also seen for the ethanolamine fragments.
These assignments were further supported by 1H-31P
HMBC connectivity data.
Experimental Section
All purchased chemicals were used without further purifi-
cation unless stated otherwise. Solvents were dried over
activated 4 A˚ (CH2Cl2, pyridine) molecular sieves. Cation-
exchange resin DOWEX 50 H? was regenerated by con-
secutive washing with HCl (3 M), water, and dry MeOH.
Aqueous solutions of salts were saturated unless stated
otherwise. Concentration of organic solutions was per-
formed under reduced pressure\40 C. Optical rotations
were measured with a Perkin-Elmer 243 B Polarimeter.
Thin-layer chromatography was performed on Merck pre-
coated plates: generally, on 5 9 10 cm, layer thickness
0.25 mm, silica gel 60F254; alternatively on HPTLC plates
with 2.5 cm concentration zone (Merck). Spots were
detected by dipping reagent (anisaldehyde-H2SO4). For
column chromatography, silica gel (0.040–0.063 mm) was
used. HP-column chromatography was performed on pre-
packed columns (YMC-Pack SIL-06, 0.005 mm,
25 9 1 cm and 25 9 2 cm). NMR spectra were recorded
with a Bruker Avance III 600 instrument (600.22 MHz for
1H, 150.93 MHz for 13C, and 242.97 MHz for 31P) using
the standard Bruker NMR software. 1H spectra were ref-
erenced to 7.26 (CDCl3) and 0.00 (D2O, external
calibration to 2,2-dimethyl-2-silapentane-5-sulfonic acid)
ppm unless stated otherwise. 13C spectra were referenced
to 77.00 (CDCl3), 49.00 (MeOD), and 67.40 (D2O, external
calibration to 1,4-dioxane) ppm. 31P spectra were refer-
enced to 0.00 ppm (orthophosphoric acid) for solutions in
D2O and according to [25] for solutions in CDCl3. ESI–MS
data were obtained on a Waters Micromass Q-TOF Ultima
Global instrument.
Scheme 2
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Methyl 2,3-O-(1-endo-ethoxybenzylidene)-4-O-[benzyl-2-
(benzyloxycarbonylamino)ethylphosphono]-6,7-O-(1,1,3,3-
tetraisopropyl-1,3-disiloxane-1,3-diyl)-L-glycero-a-D-
manno-heptopyranoside (5a, 5b, C46H68NO14PSi2)
and methyl 2,3-O-(1-exo-ethoxybenzylidene)-4-O-[benzyl-
2-(benzyloxycarbonylamino)ethylphosphono]-6,7-O-
(1,1,3,3-tetraisopropyl-1,3-disiloxane-1,3-diyl)-L-glycero-
a-D-manno-heptopyranoside (6a, 6b, C46H68NO14PSi2)
Compound 1 (57.5 mg, 0.123 mmol) was coevaporated
with dry toluene, and the residue was dissolved in 1.4 cm3
dry CH2Cl2 under Ar. a,a,a-Triethoxytoluene (33.5 mm
3,
0.148 mmol) and 1.2 mg solid camphor sulfonic acid
(6 lmol) were then added at rt and the solution was stirred
for 1 h. Triethylamine (21.8 mm3, 0.156 mmol) was then
added, the solution was concentrated, and the residue was
coevaporated with toluene. The residue was dissolved in
1.4 cm3 dry CH2Cl2, and 79.3 mm
3 phosphoramidite
reagent 4 (0.18 mmol) was added followed by dropwise
addition of 0.36 cm3 (of a 0.45 M solution of 1H-tetrazole
in acetonitrile. Additional amounts of 4 (4 9 30 mm3,
0.277 mmol) and the 0.45 M solution of 1H-tetrazole in
acetonitrile (1 9 0.17 cm3 and 3 9 0.13 cm3,
0.269 mmol) were added in four portions over 200 min.
The reaction mixture was then cooled to -78 C, and a
solution of 166 mg meta-chloroperbenzoic acid (77%
content, 0.739 mmol) in 1.5 cm3 dry CH2Cl2 was added
and stirred at -78 C for 45 min. TEA (0.137 cm3) was
then added, and the mixture allowed to warm up to rt. The
reaction mixture was then transferred into a two-phase
solution of aqueous NaHCO3 and EtOAc (each 20 cm
3)
followed by phase separation. The aqueous phase was
extracted once more with 10 cm3 EtOAc. The combined
organic phases were washed with brine, dried (Na2SO4),
and concentrated. The residue was subjected to chromatog-
raphy on silica gel (2 g, hexane/EtOAc = 3/1 ? 2.5/1,
containing 0.5% TEA) which gave a product fraction
(67 mg) and a fraction containing byproducts (49 mg). The
latter fraction was rechromatographed to afford an addi-
tional amount of product (25.9 mg). The combined product
fractions were then submitted to MPLC separation (hex-
ane/EtOAc = 3.5/1, containing 0.3% TEA) which afforded
a mixture of endo-orthoester 5a and 5b (16.1 mg, 14%) and
exo-orthoester 6a and 6b (49.7 mg, 42%) as oils. Both
fractions were further separated by HPLC (hexane/
EtOAc = 3/1, containing 0.3% TEA) which gave endo-
isomer 5a (5.0 mg) and endo-isomer 5b; Rf = 0.57 (hex-
ane/EtOAc = 1:1); oil.
1H NMR (600 MHz, CDCl3) for 5a: d = 7.52–7.48 (m,
2H, HAr), 7.38–7.35 (m, 2H, HAr), 7.35–7.26 (m, 11H,
HAr), 5.40 (bs, 1H, NH), 5.14 (dd, JH,P = 7.8 Hz,
J = 11.9 Hz, 1H, POCH2Ph), 5.07 (dd, JH,P = 9.2 Hz,
J = 11.9 Hz, 1H, POCH2Ph), 5.03–5.00 (m, 2H, CH2Ph),
5.00 (ddd, JH,P = 8.9 Hz, J = 6.9, 10.0 Hz, 1H, H-4), 4.94
(s, 1H, H-1), 4.54 (app t, J = J = 6.9 Hz, 1H, H-3), 4.35
(app d, J = 8.7 Hz, 1H, H-6), 4.13 (dd, J = 8.8,
J = 12.2 Hz, 1H, H-7a), 4.17–4.05 (m, 2H, NCH2CH2OP),
3.98 (dd, J = 0.8, J = 6.8 Hz, 1H, H-2), 3.86 (dd, J = 1.4,
J = 12.2 Hz, 1H, H-7b), 3.82–3.73 (m, 2H, OCH2CH3),
3.65 (dd, J = 1.4, J = 10.1 Hz, 1H, H-5), 3.46–3.40 (m,
2H, CH2N), 3.37 (s, 3H, OCH3), 1.17 (t, J = 7.1 Hz, 3H,
OCH2CH3), 1.12–0.92 (m, 28H, TIPDS) ppm;
13C NMR
(151 MHz, CDCl3): d = 138.8 (C-1
Ar), 129.0, 128.6,
128.4, 128.2, 128.1, 128.0, 127.9, 125.9 (CAr), 121.8 (Cq,
orthoester), 98.3 (C-1), 76.6 (C-3), 75.4 (C-2), 74.9 (d,
JC,P = 5.5 Hz, C-4), 73.6 (C-6), 69.6 (d, JC,P = 5.5 Hz,
POCH2), 68.9 (d, JC,P = 9.9 Hz, C-5), 68.3 (C-7), 67.2 (d,
JC,P = 5.5 Hz, NCH2CH2OP), 66.7 (CH2Ph), 59.2 (OCH2-
CH3), 55.4 (OCH3), 41.5 (d, JC,P = 7.7 Hz, NCH2), 17.7,
17.6, 17.4, 17.34, 17.28, 17.25, 17.2 (8 9 TIPDS-CH3),
14.9 (OCH2CH3), 13.33, 13.30, 12.7, 12.6 (4 9 TIPDS-
CH) ppm; 31P NMR (243 MHz, CDCl3): d = -2.36 ppm.
Table 1 13C and 31P NMR
chemical shifts (d/ppm) and
coupling constants (J/Hz) of 10
and 16 in D2O (27 C)
Pos. 10 16
13C JC,P
13C JC,P
1 101.64 – 101.58 –
2 70.91 – 69.98 –
3 70.91 – 77.16 6.2
4 72.51 6.1 65.85 6.3
5 71.01 5.3 71.93 –
6 69.34 – 69.64 –
7 63.21 – 63.69 –
70 – – – –
POCH2 63.13 5.5 62.81 n.d.
NCH2 40.87 7.8 40.89 7.2
OCH3 55.59 – 55.61 –
n.d. not determined
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1H NMR (600 MHz, CDCl3) for 5b: d = 7.48–7.45 (m,
2H, HAr), 7.39–7.36 (m, 2H, HAr), 7.36–7.26 (m, 11H,
HAr), 5.33 (bs, 1H, NH), 5.17 (dd, JH,P = 8.0 Hz,
J = 11.9 Hz, 1H, POCH2Ph), 5.14 (dd, JH,P = 9.3 Hz,
J = 11.8 Hz, 1H, POCH2Ph), 5.07–5.02 (m, 2H, CH2Ph),
4.99 (app dt, JH,P = 7.0 Hz, J = 9.6 Hz, 1H, H-4), 4.95 (s,
1H, H-1), 4.62 (app t, J = 7.1 Hz, 1H, H-3), 4.33 (app d,
J = 8.7 Hz, 1H, H-6), 4.13 (dd, J = 8.6, J = 12.2 Hz, 1H,
H-7a), 4.10–4.04 (m, 2H, NCH2CH2OP), 3.98 (d,
J = 6.9 Hz, 1H, H-2), 3.86 (app d, J = 12.1 Hz, 1H,
H-7b), 3.81–3.75 (OCH2CH3), 3.68 (dd, J = 1.3,
J = 9.9 Hz, 1H, H-5), 3.47–3.35 (m, 2H, CH2N), 3.34 (s,
3H, OCH3), 1.18 (t, J = 7.1 Hz, 3H, CH3), 1.13–0.93 (m,
28H, TIPDS) ppm; 13C NMR (151 MHz, CDCl3):
d = 138.8 (C-1Ar), 136.5 (C-1Ar), 135.9 (d, JC,P = 6.6 Hz,
C-1Ar), 129.0, 128.6, 128.6, 128.5, 128.2, 128.1, 128.0,
127.9, 125.9 (CAr), 121.8 (Cq, orthoester), 98.3 (C-1), 76.4
(C-3), 75.5 (C-2), 75.0 (d, JC,P = 6.1 Hz, C-4), 73.6 (C-6),
69.8 (d, JC,P = 5.3 Hz, POCH2), 68.9 (d, JC,P = 9.9 Hz,
C-5), 68.3 (C-7), 67.0 (d, JC,P = 5.5 Hz, NCH2CH2OP),
66.7 (CH2Ph), 59.2 (OCH2CH3), 55.4 (OCH3), 41.4 (d,
JC,P = 7.7 Hz, NCH2), 17.7, 17.6, 17.4, 17.34, 17.27,
17.26, 17.2 (8 9 TIPDS-CH3),15.0 (OCH2CH3), 13.3,
13.2, 12.7, 12.6 (4 9 TIPDS-CH) ppm; 31P NMR
(243 MHz, CDCl3): d = -2.52 ppm.
HPLC separation (hexane/EtOAc = 2.5/1) of the exo-
orthoester fraction afforded exo-isomer 6a (22.7 mg) and
exo-isomer 6b (18.5 mg); Rf = 0.45 (hexane/EtOAc = 1/
1); oil.
1H NMR (600 MHz, CDCl3) for 6a: d = 7.66–7.61 (m,
2H, HAr), 7.35–7.28 (m, 13H, HAr), 5.41 (bs, 1H, NH),
5.08–5.04 (m, 3H, 2 9 CH2Ph, POCH2Ph), 5.00 (s, 1H,
H-1), 4.91 (dd, JH,P = 9.5, J = 11.8 Hz, 1H, POCH2Ph),
4.76 (app t, J = 6.6 Hz, 1H, H-3), 4.50 (app dt, JH,P = 6.8,
J = 9.7 Hz, 1H, H-4), 4.49 (d, J = 6.7 Hz, 1H, H-2), 4.26
(app d, J = 8.7 Hz, 1H, H-6), 4.07 (dd, J = 8.7, 12.2 Hz,
1H, H-7a), 4.04–3.93 (m, 2H, NCH2CH2OP), 3.81 (dd,
J = 1.4, J = 12.1 Hz, 1H, H-7b), 3.62 (dd, J = 1.5,
J = 9.9 Hz, 1H, H-5), 3.37 (s, 3H, OCH3), 3.41–3.27 (m,
4H, CH2N, OCH2CH3), 1.10 (t, J = 7.05 Hz, 3H, CH3),
1.08–0.79 (m, 28H, TIPDS) ppm; 13C NMR (151 MHz,
CDCl3): d = 156.4 (NC=O), 136.7 (C-1
Ar), 136.5 (C-1Ar),
135.7 (d, J = 6.6 Hz, C-1Ar), 129.2, 128.6, 128.4, 128.2,
128.1, 128.0, 127.9, 126.4 (CAr), 120.9 (Cq, orthoester),
98.0 (C-1), 77.5 (C-3), 75.5 (C-2), 75.1 (d, JC,P = 6.6 Hz,
C-4), 73.3 (C-6), 69.5 (d, JC,P = 5.5 Hz, POCH2), 68.5 (d,
JC,P = 9.9 Hz, C-5), 68.1 (C-7), 67.1 (d, J = 5.5 Hz,
NCH2CH2OP), 66.7 (CH2Ph), 59.5 (OCH2CH3), 55.4
(OCH3), 41.4 (d, JC,P = 5.5 Hz, NCH2), 17.6, 17.5, 17.4,
17.3, 17.24, 17.21, 17.1 (8 9 TIPDS-CH3), 15.1 (OCH2-
CH3), 13.3, 13.2, 12.7, 12.6 (4 9 TIPDS-CH) ppm;
31P
NMR (243 MHz, CDCl3): d = -2.58 ppm.
1H NMR (600 MHz, CDCl3) for 6b: d = 7.67–7.62 (m,
2H, HAr), 7.36–7.27 (m, 13H, HAr), 5.29 (bs, 1H, NH), 5.07
(s, 2H, CH2Ph), 5.04 (dd, JH,P = 8.0, J = 11.9 Hz, 1H,
POCH2Ph), 5.00 (s, 1H, H-1), 4.99 (dd, JH,P = 9.6,
J = 11.9 Hz, 1H, POCH2Ph), 4.83 (app t, J = 6.7 Hz,
1H, H-3), 4.50 (d, J = 6.2 Hz, 1H, H-2), 4.46 (app dt,
JH,P = 6.9, J = 10.3 Hz, 1H, H-4), 4.26 (app d,
J = 8.7 Hz, 1H, H-6), 4.07 (dd, J = 8.9, J = 12.2 Hz,
1H, H-7a), 4.00–3.91 (m, 2H, NCH2CH2OP), 3.81 (dd,
J = 1.4, J = 12.2 Hz, 1H, H-7b), 3.68 (dd, J = 1.5,
J = 9.9 Hz, 1H, H-5), 3.37 (s, 3H, OCH3), 3.39–3.25 (m,
4H, CH2N, OCH2CH3), 1.10 (t, J = 7.0 Hz, 3H, CH3),
1.08–0.78 (m, 28H, TIPDS) ppm; 13C NMR (151 MHz,
CDCl3): d = 156.3 (NC=O), 136.9 (C-1
Ar), 136.5 (C-1Ar),
135.8 (d, JC,P = 6.3 Hz, C-1
Ar), 129.1, 128.54, 128.53,
128.46, 128.2, 128.08, 128.06, 127.9, 126.4 (CAr), 120.8
(Cq, orthoester), 98.0 (C-1), 77.3 (C-3), 75.7 (C-2), 75.4 (d,
JC,P = 6.6 Hz, C-4), 73.3 (C-6), 69.7 (d, JC,P = 5.5 Hz,
POCH2), 68.5 (d, JC,P = 8.8 Hz, C-5), 68.0 (C-7), 67.0 (d,
JC,P = 5.5 Hz, NCH2CH2OP), 66.7 (CH2Ph), 59.4 (OCH2-
CH3), 55.4 (OCH3), 41.3 (d, JC,P = 7.7 Hz, NCH2), 17.5,
17.43, 17.38, 17.3, 17.24, 17.21, 17.1 (8 9 TIPDS-CH3),
15.1 (OCH2CH3), 13.2, 13.1, 12.7, 12.6 (4 9 TIPDS-CH)
ppm; 31P NMR (243 MHz, CDCl3): d = -3.07 ppm;
HRMS (?ESI-TOF): m/z calcd for C46H68NO14PSi2
([M?Na]?) 968.3808, found 968.3822.
Methyl 2-O-benzoyl-4-O-[benzyl-2-(benzyloxycarbonyl-
amino)ethylphosphono]-6,7-O-(1,1,3,3-tetraisopropyl-1,3-
disiloxane-1,3-diyl)-L-glycero-a-D-manno-heptopyranoside
(7, C44H64NO14PSi2)
A solution of exo/endo-orthoester 5a and 6a (26 mg,
27.5 lmol) in 2.6 cm3 CH2Cl2 was stirred with 0.64 mg
camphorsulfonic acid (2.75 lmol) for 1 h at rt. Triethy-
lamine (3.8 mm3) was added, and the mixture was
concentrated. The residue was purified by chromatography
on silica gel (hexane/EtOAc = 2/1 ? 3/1) which gave
22.9 mg (91%) 7 as colorless oil; Rf = 0.26 (hexane/
EtOAc = 1/1); [a]D
20 = ?27.3 cm2 g-1 (c = 1.8, CHCl3);
1H NMR (600 MHz, CDCl3): d = 8.05–8.00 (m, 2H, H-2/
H-6Ar), 7.56–7.51 (m, 1H, H-4Ar), 7.41–7.37 (m, 2H, H-3/
H-5Ar), 7.37–7.27 (m, 10H, HAr), 5.37 (dd, J = 1.6,
3.6 Hz, 1H, H-2), 5.28 (bs, 1H, NH), 5.10 (d, JH,P = 8.9 -
Hz, 2H, POCH2Ph), 5.03 (d, J = 12.3 Hz, 1H, CH2Ph),
4.97 (d, J = 12.3 Hz, 1H, CH2Ph), 4.79 (d, J = 1.5 Hz,
1H, H-1), 4.78 (app q, J = 9.3 Hz, 1H, H-4), 4.43 (d,
J = 5.3 Hz, 1H, 3-OH), 4.35 (ddd, J = 3.9, J = 5.3,
J = 9.4 Hz, 1H, H-3), 4.31 (app d, J = 8.6 Hz, 1H,
H-6), 4.13–4.04 (m, 3H, H-7a, NCH2CH2OP), 3.80 (dd,
J = 1.1, J = 12.4 Hz, 1H, H-7b), 3.62 (dd, J = 1.1,
J = 9.6 Hz, 1H, H-5), 3.47–3.40 (m, 1H, CH2N),
3.40–3.32 (m, 1H, CH2N), 3.34 (s, 3H, OCH3), 1.15–0.83
(m, 28H, TIPDS) ppm; 13C NMR (151 MHz, CDCl3):
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d = 165.8 (C=O), 156.3 (NC=O), 136.4 (C-1Ar), 135.4 (d,
JC,P = 6.7 Hz, C-1
Ar), 133.3 (C-4Ar), 129.9 (C-2/C-6Ar),
129.6 (C-1Ar), 128.8, 128.68, 128.67, 128.5, 128.3, 128.03,
128.01, 127.97 (CAr), 98.4 (C-1), 76.9 (d, JC,P = 6.6 Hz,
C-4), 73.4 (C-6), 72.4 (C-2), 71.0 (d, JC,P = 9.5 Hz, C-5),
70.1 (d, JC,P = 5.5 Hz, POCH2), 68.4 (C-3), 68.1 (C-7),
67.6 (d, JC,P = 5.4 Hz, NCH2CH2OP), 66.7 (CH2Ph), 55.2
(OCH3), 41.3 (d, JC,P = 5.5 Hz, NCH2), 17.6, 17.5, 17.34,
17.33, 17.30, 17.25, 17.2, 17.1 (8 9 TIPDS-CH3), 13.4,
13.3, 12.6 (4 9 TIPDS-CH) ppm; 31P NMR (243 MHz,
CDCl3): d = -0.38 ppm; HRMS (
?ESI-TOF): m/z calcd
for C44H65NO14PSi2 ([M?H]
?) 918.3676, found 918.3673.
Methyl 2-O-benzoyl-4-O-[benzyl-2-(benzyloxycarbonyl-
amino)ethylphosphono]-L-glycero-a-D-manno-heptopyra-
noside (8, C32H38NO13P)
A solution of 20.5 mg 7 (22.3 lmol) in 1 cm3 CH2Cl2 was
transferred to a Teflon-flask and cooled to ice-bath
temperature. TREAT (73 mm3, 0.45 lmol) was added,
and the solution was vigorously stirred at rt. Additional
portions of TREAT (2 9 27 lcm3, 0.17 lmol) were added
after 4 and 7.5 h reaction time. After 10 h, the solution was
transferred into an ice-cold solution of aqueous NaHCO3
(5 cm3) followed by extraction with 10 cm3 portions of
EtOAc. The combined organic layer was washed with
brine, dried (Na2SO4), and concentrated. The crude residue
(17.4 mg) was purified by chromatography on a Biotage
Isolute Flash Si II column using hexane/EtOAc = 1/
2 ? EtOAc for elution, which afforded 11.5 mg (83%) 8
as colorless syrup. Rf = 0.19 (EtOAc); [a]D
20 = ?0.3 -
cm2 g-1 (c = 1.25, CHCl3);
1H NMR (600 MHz, CDCl3):
d = 8.05–8.02 (m, 2H, H-2/H-6 Ar), 7.58–7.54 (m, 1H,
H-4Ar), 7.44–7.40 (m, 2H, H-3/H-5Ar), 7.40–7.27 (m, 10H,
HAr), 5.42 (bs, 1H, NH), 5.37 (dd, J = 1.6, J = 3.6 Hz,
1H, H-2), 5.13 (d, JH,P = 8.8 Hz, 2H, POCH2Ph), 5.01 (d,
J = 12.1 Hz, 1H, CH2Ph), 4.98 (d, J = 12.1 Hz, 1H,
CH2Ph), 4.84 (br s, 1H, H-1), 4.79 (app q, J = 9.7 Hz, 1H,
H-4), 4.27 (ddd, J = 3.7, J = 5.7, J = 9.4 Hz, 1H, H-3),
4.15–4.04 (m, 2H, NCH2CH2OP), 3.99–3.95 (m, 1H, H-6),
3.85 (dd, J = 7.5, J = 10.8 Hz, 1H, H-7a), 3.73 (br d,
J = 9.8 Hz, 1H, H-5), 3.66–3.59 (m, 1H, H-7b), 3.53 (bs,
1H, 3-OH), 3.47 (bs, 1H, 6-OH), 3.42–3.36 (m, 2H,
CH2N), 3.37 (s, 3H, OCH3), 2.16 (bs, 1H, 7-OH) ppm;
13C
NMR (151 MHz, CDCl3): d = 166.0 (C=O), 156.5
(NC=O), 136.3 (C-1Ar), 135.2 (d, JC,P = 6.6 Hz, C1
Ar),
133.5 (C-4Ar), 129.9 (C-2/C-6Ar), 129.3 (C-1Ar), 128.9,
128.7, 128.5, 128.5, 128.12, 128.05, 128.0 (CAr), 98.7 (C-
1), 74.9 (d, JC,P = 5.5 Hz, C-4), 72.4 (C-2), 70.4 (d,
JC,P = 6.1 Hz, C-5), 70.3 (d, JC,P = 5.5 Hz, POCH2), 68.7
(d, JC,P = 2.6 Hz, C-3), 68.4 (C-6), 67.5 (d, JC,P = 6.3 Hz,
NCH2CH2OP), 66.8 (CH2Ph), 63.5 (C-7), 55.4 (OCH3),
41.1 (d, JC,P = 6.6 Hz, NCH2) ppm;
31P NMR (243 MHz,
CDCl3): d = 0.24 ppm; HRMS (
?ESI-TOF): m/z calcd for
C32H39NO13P ([M?H]
?) 676.2154, found 676.2164.
Methyl 4-O-(2-aminoethylphosphono)-2-O-benzoyl-L-glyc-
ero-a-D-manno-heptopyranoside (9, C17H26NO11P)
A suspension of 20.0 mg 8 (0.03 mmol) and 4.6 mg Pd–C
(10%) in 2 cm3 MeOH was hydrogenated at atmospheric
pressure for 7 h at rt. The suspension was filtered over
Celite and thoroughly rinsed with MeOH. The filtrate
was concentrated to give 12.4 mg (93%) 9 as amorphous
glass.
Rf = 0.64 (CHCl3/MeOH/H2O = 5/4/1); [a]D
20 =
?8.4 cm2 g-1 (c = 1.25, MeOH); 1H NMR (600 MHz,
MeOD): d = 8.13–8.08 (m, 2H, H-2/H-6Ar), 7.64–7.59 (m,
1H, H-4Ar), 7.51–7.46 (m, 2H, H-3/H-5Ar), 5.30 (dd,
J = 1.2, 3.2 Hz, 1H, H-2), 4.79 (br s, 1H, H-1), 4.61 (app
q, J = 9.5 Hz, 1H, H-4), 4.21–4.15 (m, 2H, H-3, CH2OP),
4.15–4.08 (m, 2H, H-6, CH2OP), 3.77 (app d, J = 9.2 Hz,
1H, H-5), 3.75 (dd, J = 6.9, J = 10.5 Hz, 1H, H-7a), 3.69
(dd, J = 6.6, J = 10.7 Hz, 1H, H-7b), 3.41 (s, 3H, OCH3),
3.19–3.11 (m, 2H, CH2N) ppm;
13C NMR (151 MHz,
MeOD): d = 167.4 (C=O), 134.5 (C-4Ar), 131.2 (C-1Ar),
131.0 (C-2/C-6Ar), 129.5 (C-3/C-5Ar), 100.1 (C-1), 74.1 (C-
2), 73.2 (d, JC,P = 5.8 Hz, C-4), 71.8 (d, JC,P = 5.5 Hz,
C-5), 70.7 (C-3), 70.03 (C-6), 63.5 (C-7), 63.2 (d,
JC,P = 5.3 Hz, CH2OP), 55.6 (OCH3), 41.5 (d,
JC,P = 7.7 Hz, CH2N) ppm;
31P NMR (243 MHz, D2O):
d = 0.99 ppm; HRMS (?ESI-TOF): m/z calcd for C17H27
NO11P ([M?H]
?) 452.1316, found 452.1323.
Methyl 4-O-(2-aminoethylphosphono)-L-glycero-a-D-
manno-heptopyranoside (10, C10H21NO10P)
A solution of 11.8 mg 9 (26 lmol) was coevaporated with
toluene. The residue was dissolved in 1.2 cm3 dry MeOH
and stirred with 0.1 cm3 1 M methanolic NaOMe for 4.5 h
at rt. The solution was made neutral by the addition of
Dowex 50 cation-exchange resin (H?-form). The suspen-
sion was filtered, and the filtrate was concentrated. The
residue was dissolved in 1 cm3 D2O and extracted three
times with 1.5 cm3 portions of diethylether. The combined
organic phase was re-extracted with 0.7 cm3 D2O, filtered
over glass-wool, and purged with argon to remove residual
ether. The aqueous phase was lyophilized to give 7.1 mg
(78%) 10 as amorphous solid. Rf = 0.17 (CHCl3/MeOH/
H2O = 5/4/1); [a]D
20 = ?43 cm2 g-1 (c = 0.7, H2O) (Ref.
[10]: [a]D
20 = ?37 cm2 g-1 (c = 1.0, H2O)); 1H NMR
(600 MHz, D2O, pD *7.5 to 8.0): d = 4.74 (d,
J = 1.5 Hz, 1H, H-1), 4.31 (app q, J = 9.5 Hz, 1H,
H-4), 4.19–4.10 (m, 2H, CH2OP), 4.04 (ddd, J = 1.3,
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J = 5.4, J = 7.6 Hz, 1H, H-6), 3.92 (dd, J = 1.7,
J = 3.5 Hz, 1H, H-2), 3.89 (dd, J = 3.5, J = 9.2 Hz,
1H, H-3), 3.74 (dd, J = 7.6, J = 11.3 Hz, 1H, H-7a), 3.70
(dd, J = 5.4, J = 11.3 Hz, 1H, H-7b), 3.67 (dd, J = 1.2,
J = 9.8 Hz, 1H, H-5), 3.35 (s, 3H, OCH3), 3.27–3.21 (m,
2H, CH2N) ppm;
13C NMR (151 MHz, D2O): see Table 1;
31P NMR (243 MHz, D2O): d = 0.35 ppm; HRMS (
-ESI-
TOF): m/z calcd for C10H20NO10P ([M-H]
-) 346.0909,
found 346.0906.
Methyl 2-O-acetyl-6,7-O-(1,1,3,3-tetraisopropyl-1,3-di-
siloxane-1,3-diyl)-L-glycero-a-D-manno-heptopyranoside
(12, C22H44O9Si2)
1,1,1-Trimethoxyethane (35 mg, 0.291 mmol) and 3 mg
camphorsulfonic acid (0.012 mmol) were added to a
solution of 113 mg heptoside 1 (0.242 mmol) in 1 cm3
dry CH2Cl2 and stirred for 1 h at rt when TLC showed full
conversion of 1 into intermediate 11 (Rf = 0.33, hexane/
EtOAc = 2/1). Water (0.01 cm3) and triethylamine
(0.01 cm3) were then added, and stirring was continued
for 30 min at rt. The solution was diluted with CH2Cl2, and
the organic layer was extracted with aqueous NaHCO3 and
brine. The organic phase was dried (Na2SO4) and concen-
trated, and the residue was purified via flash
chromatography (Isolute Flash Si II 2 g/6 cm3, hexane/
EtOAc = 2/1) and by HPLC (column YMC-Pack-Sil-06
250 9 20 mm, hexane/EtOAc = 4/1 ? 2/1) to give
88 mg (71%) 12 as syrup. Rf = 0.59 (hexane/
EtOAc = 1/1); [a]D
21 = ?22.6 cm2 g-1 (c = 1.2,
CHCl3);
1H NMR (600 MHz, CDCl3): d = 5.02 (dd, 1H,
J = 3.3, J = 1.7 Hz, H-2), 4.69 (d, 1H, J = 1.6 Hz, H-1),
4.33–4.30 (m, 1H, H-6), 4.06–4.02 (m, 1H, H-7a),
4.00–3.91 (m, 3H, H-3, H-4, H-7b), 3.57 (dd, 1H,
J = 2.5, J = 9.2 Hz, H-5), 3.33 (s, 3H, OCH3), 2.10 (s,
3H, OAc), 1.13–0.93 (m, 28H, TIPDS) ppm; 13C NMR
(151 MHz, CDCl3): d = 170.76 (C=O), 98.5 (C-1), 74.7
(C-6), 71.8 (C-2), 71.65 (C-5), 70.4 (C-3), 67.9 (C-4), 67.6
(C-7), 55.0 (OCH3), 20.85 (OAc), 17.5, 17.4, 17.36, 17.34,
17.28, 17.27, 17.22, 13.1, 12.7 (d.i.), 12.4 (TIPDS) ppm;
HRMS (ESI): m/z calcd for C22H44O9Si2 ? H
? ([M?H]?)
509.2597, found 509.2614.
Methyl 2-O-acetyl-3-O-[benzyl-(2-N-benzyloxycarbonyl-
aminoethyl)phosphono]-6,7-O-(1,1,3,3-tetraisopropyl-1,3-
disiloxane-1,3-diyl)-L-glycero-a-D-manno-heptopyranoside
(13, C39H62NO14PSi2)
A suspension of 15 mg 12 (29 lmol), 26 mg 4 (59 lmol),
and molecular sieves 4 A˚ in 0.2 cm3 dry CH2Cl2 was
stirred for 1 h at rt under Ar. Then, a 0.45 M solution of
1H-tetrazole in acetonitrile (131 mm3, 59 lmol) was
added, and stirring was continued for 2 h. The reaction
mixture was cooled to -78 C, and 10 mg mCPBA (59
lmol) was added. After 1 h, the reaction was quenched by
addition of 10 mm3 triethylamine and warmed up to rt. The
suspension was diluted with CH2Cl2 and washed with
saturated aqueous NaHCO3 and brine. The organic layer
was dried (Na2SO4) and concentrated. The residue was
purified by HPLC (YMC-Pack-SiI-06, hexane/EtOAc = 2/
1 ? 1/2) which gave 8.2 mg (32%) 13 as diastereoiso-
meric mixture. Rf = 0.45 (hexane/EtOAc = 1/1);
1H NMR
(600 MHz, CDCl3) for major isomer a: d = 7.38–7.28 (m,
10H, HAr), 5.38 (bs, 1H, NH), 5.19 (dd, 1H, J = 1.9,
J = 3.5 Hz, H-2), 5.10–5.08 (m, 4H, 2 9 CH2Ph), 4.65 (br
s, 1H, H-1), 4.63 (ddd, 1H, J = 9.5, JP,3 = 7.6 Hz, H-3),
4.35 (dt, 1H, J = 8.9, J = 1.5 Hz, H-6), 4.13 (t, 1H,
J = 9.5 Hz, H-4), 4.13–4.09 (m, 1H, POCH2CH2),
4.07–4.02 (m, 1H, POCH2CH2), 4.03 (dd, 1H, J = 12.0,
J = 8.7 Hz, H-7a), 3.85 (br d, 1H, J = 11.9 Hz, H-7b),
3.51 (br d, 1H, J = 8.9 Hz, H-5), 3.48–3.39 (m, 2H,
NCH2CH2), 3.28 (s, 3H, OCH3), 2.01 (s, 3H, OAc),
1.13–0.86 (m, 28H, TIPDS) ppm; 31P NMR (243 MHz,
CDCl3): d = 0.52 ppm;
1H NMR (600 MHz, CDCl3) for
minor isomer b: d = 7.41–7.28 (m, 10H, HAr), 5.28 (bs,
1H, NH), 5.16 (dd, 1H, J = 1.9, J = 3.5 Hz, H-2),
5.12–5.05 (m, 4H, 2 9 CH2Ph), 4.65 (d, 1H, J = 1.9 Hz,
H-1), 4.59 (ddd, 1H, J = 3.3, JH,P = 7.5, J = 9.6 Hz,
H-3), 4.36 (br d, 1H, J = 8.9 Hz, H-6), 4.15 (t, 1H,
J4,5 = J4,3 = 9.5 Hz, H-4), 4.11–4.01 (m, 3H, POCH2CH2,
H-7a), 3.87 (dd, 1H, J = 1.05 Hz, J = 12.15 Hz, H-7b),
3.58 (br s, 1H), 3.50 (dd, 1H, J = 9.5, J = 1.6 Hz, H-5),
3.42–3.36 (br s, 2H, NCH2), 3.29 (s, 3H, OCH3), 2.02 (s,
3H, OAc), 1.34–0.93 (m, 28H, TIPDS) ppm; 31P NMR
(243 MHz, CDCl3): d = 0.45 ppm;
13C NMR (150 MHz,
CDCl3): d = 170.1 (C=O), 156.4 (NC=O), 136.47; 135.49,
135.45, 128.81, 128.75, 128.7, 128.6, 128.5, 128.2, 128.11,
128.08, 128.03, 128.00, 127.5 (CAr), 54.91 (OCH3);
additional signals for isomer a: 98.3 (C-1), 77.6
(JC,P = 6.0 Hz, C-3), 73.5 (C-6), 72.51 (C-5), 70.1 (CH2-
Ph), 70.0 (C-2), 68.0 (C-7), 67.4 (JC,P = 6.2 Hz, CH2Ph),
66.1 (C-4) and 41.3 (NCH2) ppm; additional signals for
isomer b: 98.2 (C-1), 77.5 (JC,P = 6.3 Hz, C-3), 73.6 (C-
6), 72.5 (C-5), 70.1 (CH2Ph), 70.0 (C-2), 68.0 (C-7), 67.4
(JC,P = 6.2 Hz, CH2Ph), 66.1 (C-4), 41.2 (NCH2) ppm;
HRMS (ESI): m/z calcd for C39H62NO14PSi2 ? H
?
([M?H]?) 856.3519, found 856.3528.
Methyl 2-O-acetyl-3-O-[benzyl-(2-N-benzyloxycarbonyl-
aminoethyl)phosphono]-L-glycero-a-D-manno-heptopyra-
noside (14, C27H36NO13P)
A solution of 12 mg 13 (14 lmol) in 0.2 cm3 CH2Cl2 was
cooled to ice-bath temperature followed by the addition of
38 mg TREAT (0.234 mmol). The solution was stirred for
2 h at rt, a second portion of TREAT (38 mg, 0.234 mmol)
was added, and stirring was continued for 17 h. Dowex AG
1X8 anion-exchange resin (HCO3
--form) was added, the
resin was filtered off, and the filtrate was concentrated. The
residue was subjected to flash chromatography (hexane/
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EtOAc = 1/7 ? EtOAc ? EtOAc/EtOH = 9/1) which
gave 14 (6 mg, 70%) as syrup. Rf = 0.35 (EtOAc/
EtOH = 9/1); 1H NMR (600 MHz, CDCl3):
d = 7.39–7.29 (m, 10H, HAr), 5.42 (br s, *0.5H, NH-a),
5.34 (br s, *0.5H, NH-b), 5.24 (dd, *0.5H, J = 1.5,
J = 3.5 Hz, H-2b), 5.20–5.18 (m, 0.5H, H-2a), 5.11–5.06
(m, 4H, 2 9 CH2Ph), 4.65 (m, 1H, H-1a,b), 4.63 (ddd, 1H,
J = 3.7, J3,P = 7.6, J = 9.4 Hz, H-3a,b), 4.12 (t, 1H,
J4,5 = J4,3 = 9.8 Hz, H-4a,b), 4.14–4.02 (m, 3H, H-6a,b,
OPCH2CH2), 3.85–3.78 (m, 1H, H-7a,b), 3.73–3.68 (m,
1H, H-70a,b), 3.63–3.58 (m, 1H, H-5), 3.45–3.67 (m, 2H,
NCH2), 3.34 (s, 1.7H, OCH3-a), 3.32 (s, 1.3H, OCH3-b),
2.06 and 2.05 (s, 3H, OAc-a,b) ppm; 13C NMR (150 MHz,
CDCl3, selected HSQC data): d = 128.9, 128.7, 128.5,
128.0 (CAr), 98.6 (C-1), 77.3 (C-3), 72.5 (C-5), 70.2
(CH2Ph), 70.0, 69.8 (C-2), 69.9 (C-6), 67.4 (POCH2CH2),
66.9 (CH2Ph), 66.3 (C-4), 64.4 (C-7), 55.2 (OCH3), 41.5
(NCH2), 20.6 (OAc) ppm;
31P NMR (243 MHz, CDCl3):
d = 0.37, 0.22 ppm; HRMS (ESI): m/z calcd for C27H36-
NO13P ? H
? ([M?H]?) 614.1997, found 614.1995.
Methyl 2-O-acetyl-3-O-(2-aminoethylphosphono)-L-glyc-
ero-a-D-manno-heptopyranoside (15, C12H24NO11P)
A suspension of 9 mg 14 (0.015 lmol), 4 mg Pd–C (10%)
in 0.5 cm3 dry methanol, and 5 mm3 acetic acid was
hydrogenated at atmospheric pressure for 22 h at rt. The
catalyst was removed by filtration over Celite, and the
filtrate was concentrated to give 5.3 mg (93%) 15 as syrup.
Rf = 0.51 (MeOH/CHCl3/H2O = 10/10/3); [a]D
20 =
?23.2 cm2 g-1 (c = 0.5, MeOH); 1H NMR (600 MHz,
MeOD): d = 5.22 (dd, 1H, J = 3.6, J = 1.7 Hz, H-2),
4.69 (d, 1H, J = 1.7 Hz, H-1), 4.47–4.42 (dt, 1H,
J2,3 = 3.6, J3,P = J4,3 = 9.3 Hz, H-3), 4.11–3.99 (m, 4H,
H-4, H-6, POCH2CH2), 3.68 (dd, 1H, J = 10.7,
J = 6.8 Hz, H-7a), 3.65–3.62 (m, 2H, H-5, H-7b), 3.37
(s, 3H, OCH3), 3.16–3.11 (m. 2H, POCH2CH2), 2.09 (s,
3H, OAc) ppm; 13C (150 MHz, MeOD): d = 172.2 (C=O),
99.9 (C-1), 75.6 (d, 2JC-P = 5.7 Hz, C-3), 72.7 (d,
3JC-
P = 2.1 Hz, C-2), 72.5 (C-5), 70.35 (C-6), 67.2 (d,
3JC-
P = 4.4 Hz, C-4), 64.15 (C-7), 63.2 (d,
2JC-P = 5.5 Hz,
POCH2CH2), 55.4 (OCH3), 41.7 (d,
3JC-P = 6.6 Hz,
NCH2), 20.9 (OAc) ppm;
31P NMR (243 MHz, CDCl3):
d = 0.51 ppm; HRMS (ESI): m/z calcd for C12H24NO11-
P ? H? ([M?H]?) 390.1160, found 390.1168.
Methyl 3-O-(2-aminoethylphosphono)-L-glycero-a-D-
manno-heptopyranoside (16, C10H22NO10P)
A solution of 5 mg 15 (0.013 mmol) in 0.5 cm3 MeOH/
TEA/H2O = 8/1/1 was stirred for 3 days at rt. Then,
40 mm3 water were added, and stirring was continued for
4 days. The solution was concentrated, and the residue was
purified on Sephadex G-10 (H2O/EtOH = 95/5) to give
2.8 mg 16 (63%) after lyophilization. Rf = 0.32 (MeOH/
CHCl3/H2O = 5/4/1); [a]D
20 = ?18.2 cm2 g-1 (c = 0.28,
H2O);
1H NMR (600 MHz, D2O): d = 4.74 (d, 1H,
J = 1.5 Hz, H-1), 4.21 (ddd, 1H, J = 3.4, J = 9.8,
J3,P = 8.5 Hz, H-3), 4.14–4.10 (m, 2H, POCH2CH2),
4.09 (dd, 1H, H-2), 4.02 (m, 1H, J = 1.5, J = 5.5,
J = 7.5 Hz, H-6), 3.94 (t, 1H, J = 9.8 Hz, H-4), 3.72
(dd, 1H, J = 11.3 Hz, H-7a), 3.69 (dd, 1H, H-7b), 3.59
(dd, 1H, H-5), 3.35 (s, 3H, OMe), 3.25 (t, 2H, J = 5.0 Hz,
CH2N) ppm;
13C NMR data (150 MHz, D2O): see Table 1;
31P NMR (243 MHz, D2O): d = -0.29 ppm; HRMS
(ESI): m/z calcd for C10H22NO10P ? K
? ([M?K]?)
386.0614, found 386.0613.
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